Cantor Fitzgerald reiterates Varonis stock rating on acquisition news
Cantor Fitzgerald reiterated an Overweight rating and $55 price target for Varonis Systems (VRNS) after its acquisition by Proofpoint. The deal, valued at $6.3B or $49.75 per share, represents a 52% premium over VRNS's pre-rumor closing price. VRNS generated $688M in revenue with 77% gross margins over the last twelve months. The transaction is expected to close in H1 2027, subject to approvals.
How this was made
The 30-second read
Why it matters
The acquisition creates a clear catalyst for Varonis, offering a sizable premium and likely driving the stock toward the deal price, while analysts adjust targets and ratings.
Market read
The deal is a material M&A event in the cybersecurity sector, likely moving Varonis shares and influencing peer valuations.
What to watch
Potential integration risks and Proofpoint's financing structure could affect post‑deal performance.
Background
The article reports Cantor Fitzgerald reiterating an Overweight rating and a $55 price target for Varonis following the acquisition announcement.
Ticker impact
Varonis Systems announced a definitive all‑cash acquisition by Proofpoint valued at $6.3 billion, with a $49.75 per‑share offer representing a 52% premium.
upward pressure as investors price in the $49.75 cash offer and the $55 target.
The acquisition is newly disclosed, premium‑rich, and the stock is already trading below the offer price, creating upside potential.
Market effects
Strengthens the cybersecurity M&A landscape and may trigger valuation reassessments for peer data‑security firms.
U.S. market focus; limited direct regional effect beyond North America.
Highlights continued private‑equity‑driven consolidation in the global security software sector.
Counterpoint
If the deal faces regulatory or shareholder hurdles, the premium could evaporate, capping upside.
Key entities
- companyVaronis Systems
Cybersecurity data‑protection firm being acquired.
- companyProofpoint
Private cybersecurity firm owned by Thoma Bravo, acquirer.
- analystCantor Fitzgerald
Research firm reiterating Overweight rating and $55 target.

